Live Analyst Rating Changes 1619 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Tara Bancroft
TD
Tara Bancroft
TD Cowen
Wall Street Analyst
★★☆☆☆
#2171
on 13Foresight · ranked by our own returns
38%
Success Rate
-7.8%
Average Return
9 of 24 calls profitable · -12.4% vs benchmark
📈 Across the calls we could measure, roughly 38% of Tara Bancroft's ratings turned a profit when each position was held for 1 year — averaging -7.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

110 Buy 20 Hold 0 Sell
Tara's Stock Coverage 25 ratings · 2026-06-22
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
URGN
Urogen Pharma
 Jun 16, 2026 BUY Strong Buy
+13.0% avg upside
16 analysts
$35.00
4.23% Upside
 +2.7%
KLRS
Kalaris Therapeutics
 Jun 15, 2026 BUY Buy
+170.1% avg upside
13 analysts
 — ·
IRON
Disc Medicine
 Jun 03, 2026 BUY Strong Buy
+20.2% avg upside
21 analysts
 — -0.4%
CELC
Celcuity
 May 14, 2026 BUY Strong Buy
+40.6% avg upside
16 analysts
 — -34.9%
STRO
Sutro Biopharma
 May 14, 2026 BUY Strong Buy
+31.6% avg upside
20 analysts
 — -25.0%
FATE
Fate Therapeutics
 May 13, 2026 HOLD Buy
+475.7% avg upside
31 analysts
 — -7.5%
XNCR
Xencor
 May 11, 2026 BUY Strong Buy
+160.0% avg upside
27 analysts
 — -11.9%
RCKT
Rocket Pharmaceuticals
 May 10, 2026 HOLD Buy
+391.0% avg upside
29 analysts
 — -17.5%
LNTH
Lantheus
 May 07, 2026 BUY Strong Buy
-27.9% avg upside
20 analysts
$105.00
1.14% Upside
 +15.0%
WHWK
Whitehawk Therapeutics
 May 07, 2026 HOLD Buy
+201.4% avg upside
12 analysts
 — +12.2%
TGTX
TG Therapeutics
 May 06, 2026 BUY Strong Buy
-34.4% avg upside
19 analysts
$50.00
5.99% Downside
 +20.4%
GERN
Geron
 May 06, 2026 BUY Strong Buy
+239.8% avg upside
19 analysts
$3.00
138.03% Upside
 -9.5%
EYPT
EyePoint Pharmaceuticals
 May 06, 2026 BUY Strong Buy
+123.7% avg upside
17 analysts
$20.00
47.34% Upside
 -1.5%
PCVX
Vaxcyte
 May 06, 2026 BUY Strong Buy
+96.1% avg upside
15 analysts
$75.00
45.82% Upside
 -9.9%
MLYS
Mineralys Therapeutics, Inc.
 May 06, 2026 BUY Strong Buy
+82.7% avg upside
12 analysts
 — -18.2%
PTGX
Protagonist Therapeutics
 May 05, 2026 BUY Strong Buy
-22.0% avg upside
19 analysts
$100.00
11.31% Downside
 +12.3%
OCUL
Ocular Therapeutix
 May 05, 2026 BUY Strong Buy
+160.4% avg upside
21 analysts
$20.00
112.19% Upside
 -0.7%
BCYC
Bicycle Therapeutics
 Apr 30, 2026 BUY Strong Buy
+505.6% avg upside
20 analysts
 — -7.6%
NBTX
Nanobiotix
 Apr 01, 2026 BUY Strong Buy
-8.4% avg upside
5 analysts
 — +4.1%
TCRX
TScan Therapeutics
 Mar 11, 2026 BUY Strong Buy
+823.9% avg upside
12 analysts
 — -21.8%
MGNX
MacroGenics
 Mar 10, 2026 HOLD Buy
+326.1% avg upside
25 analysts
 — +21.3%
AU:TLX
Telix Pharmaceuticals
 Feb 19, 2026 BUY Strong Buy
+75.9% avg upside
13 analysts
$20.00
37.94% Upside
 ·
NCNA
Nucana
 Mar 14, 2025 HOLD Strong Buy
+559.7% avg upside
9 analysts
 — -98.8%
IMA
ImageneBio
 Aug 09, 2024 BUY Strong Buy
+179.7% avg upside
12 analysts
 — -24.8%
CBIO
Crescent Biopharma
 Jul 26, 2024 HOLD Strong Buy
+26.9% avg upside
17 analysts
 — ·
🔒 20 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Tara Bancroft — Frequently Asked Questions
How accurate are Tara Bancroft's stock ratings?
Based on the calls 13Foresight could measure, about 38% of Tara's ratings were profitable over a one-year hold, with an average return of -7.8% per rating, or -12.4% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Tara ranked on 13Foresight?
Tara Bancroft is currently ranked #2171 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Tara cover?
Tara most recently has ratings on URGN, KLRS, IRON, CELC, STRO, FATE, XNCR, RCKT, LNTH, WHWK, TGTX, GERN and 13 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.